United Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of United Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-29 | $7.16 | $6.93 | 3.32 % |
| Q2 | 2025-07-30 | $6.41 | $6.87 | -6.70 % |
| Q1 | 2025-04-30 | $6.63 | $6.53 | 1.53 % |
| Q4 | 2025-02-26 | $6.19 | $6.31 | -1.90 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-29 | $799.50M | $814.84M | -1.88 % |
| Q2 | 2025-07-30 | $798.60M | $800.49M | -0.24 % |
| Q1 | 2025-04-30 | $794.40M | $729.82M | 8.85 % |
| Q4 | 2025-02-26 | $735.90M | $734.74M | 0.16 % |
United Therapeutics (UTHR) is scheduled to report earnings on February 25, 2026. The last reported earnings were for reported on October 29, 2025 for Q3.
The Actual EPS was $7.16, which beat the estimate of $6.93.
The Actual Revenue was $799.5M, which missed the estimate of $814.8M.
Browse earnings estimates, EPS, and revenue on all stocks.